Biocodex
Records under this name other than the patents Biocodex holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Showing 1 to 7 of 7 · Back to Biocodex
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,183,008 | Treatment of Prolonged Status Epilepticus Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,141,440 | Pharmaceutical oral formulation comprising bacteria Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,420,644 | Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas Lapsed on the fee record Ended Apr 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2025 | From the USPTO record |
| US 7,799,328 | Method for treating weight loss in patients suffering from inflammatory bowel diseases Term ended Term ended Mar 25, 2025 · From the USPTO record | Term ended | Term ended Mar 25, 2025 | From the USPTO record |
| US 7,906,515 | Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation Formerly held Term ended Term ended Mar 2, 2025 · From the USPTO record | Term ended | Term ended Mar 2, 2025 | From the USPTO record |
| US 6,727,253 | Treatment of accidental extravasation of anthracyclines Formerly held Term ended Term ended Mar 13, 2020 · From the USPTO record | Term ended | Term ended Mar 13, 2020 | From the USPTO record |
| US 6,265,385 | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy Formerly held Term ended Term ended Mar 8, 2019 · From the USPTO record | Term ended | Term ended Mar 8, 2019 | From the USPTO record |